Skip to content

Apotheek Terkoest

Active
Private limited companyfounded 2003active for 23 yearsO. L. Vrouwstraat 92, 3570 Alken, BelgiumKBO/BCE: BE 0479.685.586

From the official registers: KBO 23 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Apotheek Terkoest has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €351,404 and a net result of €4,083. Equity has been stable since 2018 (±2.1% per year). Its solvency ranks better than 54% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
Apotheek TerkoestActiveChecked score 93/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 03-03-2003 Normal situation
Legal form
Private limited company
Registered office
O. L. Vrouwstraat 92, 3570 Alken
Activity
Retail sale of pharmaceutical products NACE 47730and 2 others
Establishment unit
2.126.640.668 3570 Alken, since 28-04-2003
Financial year end
31 December
Peppol
Reachable since 15-09-2025
Company details

Board and ownership

Board
  • Pharminackx BVDirector · since 03-04-2020
Shareholders
Board & ownership

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€72,063
▲ 14.2%
Turnover
≈ €350,000
estimated
Profit
€4,083
▼ 81.9%
Equity
€351,404
▲ 1.2%
Total assets
€868,114
▼ 3.8%
2025 accounts filed 32 days before the deadline
Filed on 29-06-2026at the National Bank
Financials
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskSize: total assets €868,114Founded in 2003Figures for financial year 2025 (filed on 29-06-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 51% of micro companies in retail trade (NACE 47)
Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Strong
Solvency 65+2
equity 40.5% of total assets
Liquidity 58-2
short-term debt 9.8% · cash 6.2%
Profitability 56-16
return on assets 0.5%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: 0.3% 12-2024: 0.3%● unchanged vs 11-2024 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.2%▼ -0.1 percentage points vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.1%▼ -0.1 percentage points vs 06-2026 08-2026: 0.3%▲ +0.2 percentage points vs 07-2026 09-2026: 0.4%▲ +0.1 percentage points vs 08-2026highest value 10-2026: 0.1%▼ -0.3 percentage points vs 09-2026lowest value
Credit of up to €30,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.51 (4.64 in 2024), above the usual 1.5. Short-term debt is 9.8% and cash 6.2% of total assets. However, 59.5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 56% of them on solvency, 64% on liquidity, 40% on profitability and 43% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €868,114
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Founded in 2003
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Figures for financial year 2025 (filed on 29-06-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
32 days early
2024
37 days early
2023
9 days early
2022
31 days late
2021
39 days late
2020
29 days early
2019
65 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 15 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 23 July (4 of the last 5 filed years within 39 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 5 profitable years in a rowprofit 2025: €4,083 5 years View

Documents

Annual accounts at the NBB

All 23 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Apotheek Terkoest

What is the company number of Apotheek Terkoest?
The company number of Apotheek Terkoest is 0479.685.586. The VAT number is the same number with BE in front: BE 0479.685.586.
Where is Apotheek Terkoest based?
The registered office is at O. L. Vrouwstraat 92, 3570 Alken.Company details
What does Apotheek Terkoest do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Terkoest?
The legal form of Apotheek Terkoest is Private limited company (BV).
When was Apotheek Terkoest founded?
Apotheek Terkoest was founded on 03-03-2003.
Is Apotheek Terkoest still active?
Yes, Apotheek Terkoest is an active enterprise in the KBO register.
How many employees does Apotheek Terkoest have?
Apotheek Terkoest had an average of 0.5 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
What is the turnover of Apotheek Terkoest?
The turnover in financial year 2025 is ≈ €350,000. This figure is estimated from the gross margin of €72,063 and 73 comparable companies (NACE 477). It probably lies between €170,000 and €510,000.
Is Apotheek Terkoest profitable?
In financial year 2025, Apotheek Terkoest made a profit of €4,083.
Where can I find the annual accounts of Apotheek Terkoest?
Apotheek Terkoest filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Apotheek Terkoest due?
Apotheek Terkoest must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Companies linked to Apotheek Terkoest

Comparable companies

These companies have the same main activity as Apotheek Terkoest: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €670,000 and €1.2m, founded between 1994 and 2012.

CompanyTotal assetsGross margin
Apotheek Terkoest Alken€0.9m€0.07m
APOTHEEK GEMELS Tongeren-Borgloon€0.9m€0.08m
Pharmacie de Walhain Walhain€0.9m€0.08m
APOTEEK ACKERMAN A. Gent€1.0m€0.09m
APOTHEEK VAN GLABEKE Eeklo€0.8m€0.1m
DIXIMO Ferrières€1.2m€0.06m
Pharmaconsult Beringen€0.7m€0.08m
Full comparison

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure